Search Results - "Tomimaru, Y."

Refine Results
  1. 1

    MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer by Hasegawa, S, Eguchi, H, Nagano, H, Konno, M, Tomimaru, Y, Wada, H, Hama, N, Kawamoto, K, Kobayashi, S, Nishida, N, Koseki, J, Nishimura, T, Gotoh, N, Ohno, S, Yabuta, N, Nojima, H, Mori, M, Doki, Y, Ishii, H

    Published in British journal of cancer (14-10-2014)
    “…Background: Pancreatic cancer has a poor prognosis because of its high refractoriness to chemotherapy and tumour recurrence, and these properties have been…”
    Get full text
    Journal Article
  2. 2

    MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells by Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M

    Published in British journal of cancer (09-11-2010)
    “…Background: We reported recently the clinical efficiency of interferon (IFN)- α /5-fluorouracil (5-FU) combination therapy in advanced hepatocellular carcinoma…”
    Get full text
    Journal Article
  3. 3

    miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1 by Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y

    Published in British journal of cancer (23-07-2013)
    “…Background: Gemcitabine-based chemotherapy is the standard treatment for pancreatic cancer. However, the issue of resistance remains unresolved. The aim of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    De Novo Malignancy After Pancreas Transplantation in Japan by Tomimaru, Y, Ito, T, Marubashi, S, Kawamoto, K, Tomokuni, A, Asaoka, T, Wada, H, Eguchi, H, Mori, M, Doki, Y, Nagano, H

    Published in Transplantation proceedings (01-04-2015)
    “…Abstract Background Long-term immunosuppression is associated with an increased risk of cancer. Especially, the immunosuppression in pancreas transplantation…”
    Get full text
    Journal Article
  6. 6

    Clinical Outcome of Pancreas Transplantation From Marginal Donors in Japan by Tomimaru, Y, Ito, T, Kawamoto, K, Hama, N, Wada, H, Kobayashi, S, Eguchi, H, Tanemura, M, Mori, M, Doki, Y, Nagano, H

    Published in Transplantation proceedings (01-04-2014)
    “…Abstract In Japan, absolute shortage of donors still continues even after the law allowing organ transplantation from deceased donors came into force in 1997…”
    Get full text
    Journal Article
  7. 7

    Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells by Tomimaru, Y, Eguchi, H, Wada, H, Noda, T, Murakami, M, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M, Nagano, H

    Published in British journal of cancer (11-05-2010)
    “…Background: A striking efficiency of interferon (IFN)-based anticancer therapy for advanced hepatocellular carcinoma (HCC) has been reported. Because its…”
    Get full text
    Journal Article
  8. 8

    Outcome of laparoscopic surgery for colon cancer in elderly patients by Tomimaru, Y, Ide, Y, Murata, K

    Published in Asian journal of endoscopic surgery (01-02-2011)
    “…Introduction: The aim of this study was to evaluate whether elderly patients with colorectal cancer benefit from laparoscopic colon surgery (LAC) in comparison…”
    Get full text
    Journal Article
  9. 9

    Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells by Nambotin, S B, Tomimaru, Y, Merle, P, Wands, J R, Kim, M

    Published in Oncogenesis (New York, NY) (01-10-2012)
    “…We have previously demonstrated that WNT3 and Frizzled7 (FZD7) expression levelswere upregulated in hepatocellular carcinoma (HCC) and that they directly…”
    Get full text
    Journal Article
  10. 10

    Correlation between pretherapeutic d-dimer levels and response to neoadjuvant chemotherapy in patients with advanced esophageal cancer by Tomimaru, Y., Yano, M., Takachi, K., Kishi, K., Miyashiro, I., Ohue, M., Ohigashi, H., Sasaki, Y., Ishikawa, O., Imaoka, S.

    Published in Diseases of the esophagus (01-06-2008)
    “…Neoadjuvant chemotherapy may improve survival of responders in esophageal cancer patients but is useless and harmful in non‐responders. Thus, it is important…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    230PPROGNOSTIC IMPACT OF TUMORAL AND/OR PERI-TUMORAL SPARC EXPRESSIONS AFTER SURGERY IN PATIENTS WITH BILIARY TRACT CANCER by Sakai, D., Nakashima, S., Kobayashi, S., Konno, M., Nishida, N., Kudo, T., Tomokuni, A., Tomimaru, Y., Hama, N., Wada, H., Kawamoto, K., Marubashi, S., Eguchi, H., Matsuura, N., Satoh, T., Nagano, H., Doki, Y., Mori, M.

    Published in Annals of oncology (01-09-2014)
    “…Abstract Aim: SPARC (secreted protein acidic and rich in cysteine) is a member of matricellular glycoproteins, which modulate interactions between tumoral…”
    Get full text
    Journal Article
  15. 15

    Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development by Eguchi, Hidetoshi, Ishikawa, Osamu, Ohigashi, Hiroaki, Tomimaru, Yoshito, Sasaki, Yo, Yamada, Terumasa, Tsukuma, Hideaki, Nakaizumi, Akihiko, Imaoka, Shingi

    Published in Surgery (01-06-2006)
    “…Intraductal papillary mucinous neoplasm (IPMN) of the pancreas has been recognized recently and is being diagnosed with increasing frequency. Although IPMN has…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy by Tomimaru, Yoshito, Yano, Masahiko, Takachi, Ko, Miyashiro, Isao, Ishihara, Ryu, Nishiyama, Kinji, Sasaki, Yo, Ishikawa, Osamu, Doki, Yuichiro, Imaoka, Shingi

    Published in Journal of surgical oncology (01-04-2006)
    “…Background and Objectives Although salvage surgery after definitive chemoradiotherapy (CRT) is common, the safety and indication has not yet been established…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    MicroRNA-21 induces resistance to the anti-tumour effect of interferon- 5-fluorouracil in hepatocellular carcinoma cells by Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M

    Published in British journal of cancer (09-11-2010)
    “…We reported recently the clinical efficiency of interferon (IFN)-α/5-fluorouracil (5-FU) combination therapy in advanced hepatocellular carcinoma (HCC)…”
    Get full text
    Journal Article